Skip to content

Stepan SCL Additional Paid-In Capital

Additional Paid-In Capital at other companies

Huntsman logo
HuntsmanHUN
$4.3B+0.8%
Dow logo
DowDOW
$11.06B+20.3%
Innospec logo
InnospecIOSP
$377.3M+1.8%
Eastman Chemical logo
Eastman ChemicalEMN
$2.52B+1.8%
Ashland logo
AshlandASH
$6M
Element Solutions logo
Element SolutionsESI
$4.29B+1.6%

Other financials

Income statement

See full
Revenue$604.5M+1.9%
Gross profit$64.9M-14.1%
Operating income-$49.6M-275%
Net income-$41.4M-310%
EPS (diluted)-$1.81-310%

Balance sheet

See full
Cash & equivalents$140.8M+31.0%
Total debt$713.1M-2.5%
Total equity$1.2B-0.6%
Total assets$2.3B-2.4%

Cash flow

See full
Operating cash flow$16.9M+144%
CapEx$30.9M-5.7%
Free cash flow-$14.0M+45.9%

Valuation

See full
Market cap$1.25B-8.6%
Enterprise value$1.82B-8.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin11.1%-1.4pp
Operating margin0%-3.5pp
Net margin-0.6%-3.1pp
FCF margin1.6%

Returns & leverage

See full
Return on equity-1.2%-5.8pp
Debt / equity0.6×0.0×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Stepan in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Stepan’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stepan's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stepan's additional paid-in capital?
Stepan (SCL) reported additional paid-in capital of $262.2M in Q1 2026.
How has Stepan's additional paid-in capital changed year-over-year?
Stepan's additional paid-in capital increased by 3.1% year-over-year, from $254.37M to $262.2M.
What is the long-term trend for Stepan's additional paid-in capital?
Over 5 years (2020 to 2025), Stepan's additional paid-in capital has grown at a 4.7% compound annual growth rate (CAGR), from $206.72M to $259.82M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.